Janssen v. Apotex

We successfully represented Janssen in a motion to appeal an order of the Associate Judge which declined, based on relevance, to compel Apotex to answer certain discovery questions related to its ability to supply its generic abiraterone acetate product.

This motion arose in the context of an ongoing PMNOC section 8 damages action.

Janssen’s motion was granted on the basis that the Associate Judge erred in concluding that these discovery questions were not relevant to the issues in the action.